APO Research

APO RESEARCH · REPORT

Treatment of PNH

Selected research

Market Analysis & Forecast

Global Treatment of PNH Market Analysis and Forecast 2026-2032

Market perspective

The global Treatment of PNH market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Treatment of PNH is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Treatment of PNH include Alexion Pharmaceuticals, Apellis Pharmaceuticals, Samsung Bioepis, Amgen, Roche and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Treatment of PNH, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Treatment of PNH, also provides the sales of main regions and countries. Of the upcoming market potential for Treatment of PNH, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Treatment of PNH sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Treatment of PNH market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Treatment of PNH sales, projected growth trends, production technology, application and end-user industry.

Treatment of PNH Segment by Company

Alexion Pharmaceuticals

Apellis Pharmaceuticals

Samsung Bioepis

Amgen

Roche

Novartis

Treatment of PNH Segment by Type

Complement Inhibitors

Supportive Care

Others

Treatment of PNH Segment by Application

Hospital

Clinic

Other

Treatment of PNH Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment of PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of PNH.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Treatment of PNH in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Treatment of PNH manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Treatment of PNH sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Treatment of PNH Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Complement Inhibitors Major Manufacturers Table 3. Supportive Care Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Treatment of PNH Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Treatment of PNH Industry Trends Table 10. Treatment of PNH Industry Drivers Table 11. Treatment of PNH Industry Opportunities and Challenges Table 12. Treatment of PNH Industry Restraints Table 13. Global Treatment of PNH Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Treatment of PNH Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Treatment of PNH Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Treatment of PNH Revenue Market Share by Region (2021-2026) Table 17. Global Treatment of PNH Revenue Market Share by Region (2027-2032) Table 18. Global Treatment of PNH Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Treatment of PNH Sales by Region (2021-2026) & (K Units) Table 20. Global Treatment of PNH Sales by Region (2027-2032) & (K Units) Table 21. Global Treatment of PNH Sales Market Share by Region (2021-2026) Table 22. Global Treatment of PNH Sales Market Share by Region (2027-2032) Table 23. Global Treatment of PNH Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Treatment of PNH Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Treatment of PNH Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Treatment of PNH Sales Market Share by Manufacturers (2021-2026) Table 27. Global Treatment of PNH Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Treatment of PNH Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Treatment of PNH Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Treatment of PNH Manufacturers, Product Type & Application Table 31. Global Treatment of PNH Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Treatment of PNH by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Treatment of PNH Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Treatment of PNH Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Treatment of PNH Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Treatment of PNH Revenue Market Share by Type (2021-2026) Table 38. Global Treatment of PNH Revenue Market Share by Type (2027-2032) Table 39. Global Treatment of PNH Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 41. Global Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 42. Global Treatment of PNH Sales Market Share by Type (2021-2026) Table 43. Global Treatment of PNH Sales Market Share by Type (2027-2032) Table 44. Global Treatment of PNH Price by Type (2021-2026) & (US$/Unit) Table 45. Global Treatment of PNH Price by Type (2027-2032) & (US$/Unit) Table 46. Global Treatment of PNH Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Treatment of PNH Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Treatment of PNH Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Treatment of PNH Revenue Market Share by Application (2021-2026) Table 50. Global Treatment of PNH Revenue Market Share by Application (2027-2032) Table 51. Global Treatment of PNH Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 53. Global Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 54. Global Treatment of PNH Sales Market Share by Application (2021-2026) Table 55. Global Treatment of PNH Sales Market Share by Application (2027-2032) Table 56. Global Treatment of PNH Price by Application (2021-2026) & (US$/Unit) Table 57. Global Treatment of PNH Price by Application (2027-2032) & (US$/Unit) Table 58. Alexion Pharmaceuticals Company Information Table 59. Alexion Pharmaceuticals Business Overview Table 60. Alexion Pharmaceuticals Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Alexion Pharmaceuticals Treatment of PNH Product Portfolio Table 62. Alexion Pharmaceuticals Recent Development Table 63. Apellis Pharmaceuticals Company Information Table 64. Apellis Pharmaceuticals Business Overview Table 65. Apellis Pharmaceuticals Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Apellis Pharmaceuticals Treatment of PNH Product Portfolio Table 67. Apellis Pharmaceuticals Recent Development Table 68. Samsung Bioepis Company Information Table 69. Samsung Bioepis Business Overview Table 70. Samsung Bioepis Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Samsung Bioepis Treatment of PNH Product Portfolio Table 72. Samsung Bioepis Recent Development Table 73. Amgen Company Information Table 74. Amgen Business Overview Table 75. Amgen Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Amgen Treatment of PNH Product Portfolio Table 77. Amgen Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Roche Treatment of PNH Product Portfolio Table 82. Roche Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Treatment of PNH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novartis Treatment of PNH Product Portfolio Table 87. Novartis Recent Development Table 88. North America Treatment of PNH Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Treatment of PNH Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 91. North America Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 92. North America Treatment of PNH Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Treatment of PNH Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Treatment of PNH Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Treatment of PNH Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 97. North America Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 98. North America Treatment of PNH Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Treatment of PNH Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Treatment of PNH Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Treatment of PNH Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Treatment of PNH Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 105. North America Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 106. North America Treatment of PNH Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Treatment of PNH Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 109. Canada Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 110. Mexico Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 111. Europe Treatment of PNH Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Treatment of PNH Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 114. Europe Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 115. Europe Treatment of PNH Sales Price by Type (2021-2026) & (US$/Unit) Table 116. Europe Treatment of PNH Sales Price by Type (2027-2032) & (US$/Unit) Table 117. Europe Treatment of PNH Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Treatment of PNH Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 120. Europe Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 121. Europe Treatment of PNH Sales Price by Application (2021-2026) & (US$/Unit) Table 122. Europe Treatment of PNH Sales Price by Application (2027-2032) & (US$/Unit) Table 123. Europe Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Treatment of PNH Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Treatment of PNH Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Treatment of PNH Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. Europe Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 128. Europe Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 129. Europe Treatment of PNH Sales Price by Country (2021-2026) & (US$/Unit) Table 130. Europe Treatment of PNH Sales Price by Country (2027-2032) & (US$/Unit) Table 131. Germany Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 132. France Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 133. U.K. Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 134. Italy Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 135. Russia Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 136. Spain Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 139. Sweden Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 140. Poland Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 141. China Treatment of PNH Revenue by Type (2021-2026) & (US$ Million) Table 142. China Treatment of PNH Revenue by Type (2027-2032) & (US$ Million) Table 143. China Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 144. China Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 145. China Treatment of PNH Sales Price by Type (2021-2026) & (US$/Unit) Table 146. China Treatment of PNH Sales Price by Type (2027-2032) & (US$/Unit) Table 147. China Treatment of PNH Revenue by Application (2021-2026) & (US$ Million) Table 148. China Treatment of PNH Revenue by Application (2027-2032) & (US$ Million) Table 149. China Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 150. China Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 151. China Treatment of PNH Sales Price by Application (2021-2026) & (US$/Unit) Table 152. China Treatment of PNH Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Treatment of PNH Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Treatment of PNH Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 156. Asia Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 157. Asia Treatment of PNH Sales Price by Type (2021-2026) & (US$/Unit) Table 158. Asia Treatment of PNH Sales Price by Type (2027-2032) & (US$/Unit) Table 159. Asia Treatment of PNH Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Treatment of PNH Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 162. Asia Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 163. Asia Treatment of PNH Sales Price by Application (2021-2026) & (US$/Unit) Table 164. Asia Treatment of PNH Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Treatment of PNH Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Treatment of PNH Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Treatment of PNH Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Asia Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 170. Asia Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 171. Asia Treatment of PNH Sales Price by Country (2021-2026) & (US$/Unit) Table 172. Asia Treatment of PNH Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Japan Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 174. South Korea Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 175. India Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 176. Australia Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Treatment of PNH Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Treatment of PNH Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 182. SAMEA Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 183. SAMEA Treatment of PNH Sales Price by Type (2021-2026) & (US$/Unit) Table 184. SAMEA Treatment of PNH Sales Price by Type (2027-2032) & (US$/Unit) Table 185. SAMEA Treatment of PNH Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Treatment of PNH Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 188. SAMEA Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 189. SAMEA Treatment of PNH Sales Price by Application (2021-2026) & (US$/Unit) Table 190. SAMEA Treatment of PNH Sales Price by Application (2027-2032) & (US$/Unit) Table 191. SAMEA Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Treatment of PNH Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Treatment of PNH Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Treatment of PNH Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. SAMEA Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 196. SAMEA Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 197. SAMEA Treatment of PNH Sales Price by Country (2021-2026) & (US$/Unit) Table 198. SAMEA Treatment of PNH Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Brazil Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 200. Argentina Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 201. Chile Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 202. Colombia Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 203. Peru Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 205. Israel Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 206. UAE Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 207. Turkey Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 208. Iran Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 209. Egypt Treatment of PNH Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Treatment of PNH Distributors List Table 213. Treatment of PNH Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Treatment of PNH Image Figure 2. Global Treatment of PNH Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment of PNH Market Size Share 2021 VS 2025 VS 2032 Figure 4. Complement Inhibitors Image Figure 5. Supportive Care Image Figure 6. Others Image Figure 7. Global Treatment of PNH Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Treatment of PNH Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Treatment of PNH Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Treatment of PNH Revenue (2021-2032) & (US$ Million) Figure 14. Global Treatment of PNH Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Treatment of PNH Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Treatment of PNH Revenue Market Share by Region (2021-2032) Figure 17. Global Treatment of PNH Sales (2021-2032) & (K Units) Figure 18. Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Treatment of PNH Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Treatment of PNH Sales YoY (2021-2032) & (K Units) Figure 21. Europe Treatment of PNH Sales YoY (2021-2032) & (K Units) Figure 22. China Treatment of PNH Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Treatment of PNH Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Treatment of PNH Sales YoY (2021-2032) & (K Units) Figure 25. Global Treatment of PNH Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Treatment of PNH Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Treatment of PNH Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Treatment of PNH Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Treatment of PNH Revenue Market Share by Type (2021-2032) Figure 31. Global Treatment of PNH Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Treatment of PNH Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Treatment of PNH Sales Market Share by Type (2021-2032) Figure 34. Global Treatment of PNH Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Treatment of PNH Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Treatment of PNH Revenue Market Share by Application (2021-2032) Figure 37. Global Treatment of PNH Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Treatment of PNH Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Treatment of PNH Sales Market Share by Application (2021-2032) Figure 40. North America Treatment of PNH Revenue Share by Type (2021-2032) Figure 41. North America Treatment of PNH Sales Share by Type (2021-2032) Figure 42. North America Treatment of PNH Revenue Share by Application (2021-2032) Figure 43. North America Treatment of PNH Sales Share by Application (2021-2032) Figure 44. North America Treatment of PNH Revenue Share by Country (2021-2032) Figure 45. North America Treatment of PNH Sales Share by Country (2021-2032) Figure 46. Europe Treatment of PNH Revenue Share by Type (2021-2032) Figure 47. Europe Treatment of PNH Sales Share by Type (2021-2032) Figure 48. Europe Treatment of PNH Revenue Share by Application (2021-2032) Figure 49. Europe Treatment of PNH Sales Share by Application (2021-2032) Figure 50. Europe Treatment of PNH Revenue Share by Country (2021-2032) Figure 51. Europe Treatment of PNH Sales Share by Country (2021-2032) Figure 52. China Treatment of PNH Revenue Share by Type (2021-2032) Figure 53. China Treatment of PNH Sales Share by Type (2021-2032) Figure 54. China Treatment of PNH Revenue Share by Application (2021-2032) Figure 55. China Treatment of PNH Sales Share by Application (2021-2032) Figure 56. Asia Treatment of PNH Revenue Share by Type (2021-2032) Figure 57. Asia Treatment of PNH Sales Share by Type (2021-2032) Figure 58. Asia Treatment of PNH Revenue Share by Application (2021-2032) Figure 59. Asia Treatment of PNH Sales Share by Application (2021-2032) Figure 60. Asia Treatment of PNH Revenue Share by Country (2021-2032) Figure 61. Asia Treatment of PNH Sales Share by Country (2021-2032) Figure 62. SAMEA Treatment of PNH Revenue Share by Type (2021-2032) Figure 63. SAMEA Treatment of PNH Sales Share by Type (2021-2032) Figure 64. SAMEA Treatment of PNH Revenue Share by Application (2021-2032) Figure 65. SAMEA Treatment of PNH Sales Share by Application (2021-2032) Figure 66. SAMEA Treatment of PNH Revenue Share by Country (2021-2032) Figure 67. SAMEA Treatment of PNH Sales Share by Country (2021-2032) Figure 68. Treatment of PNH Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Treatment of PNH Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Complement Inhibitors
  • Supportive Care
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Alexion Pharmaceuticals
  • Apellis Pharmaceuticals
  • Samsung Bioepis
  • Amgen
  • Roche
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Treatment of PNH Market by Type
  3. 1.2.1 Global Treatment of PNH Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Complement Inhibitors
  5. 1.2.3 Supportive Care
  6. 1.2.4 Others
  7. 1.3 Treatment of PNH Market by Application
  8. 1.3.1 Global Treatment of PNH Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Treatment of PNH Market Dynamics
  1. 2.1 Treatment of PNH Industry Trends
  2. 2.2 Treatment of PNH Industry Drivers
  3. 2.3 Treatment of PNH Industry Opportunities and Challenges
  4. 2.4 Treatment of PNH Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Treatment of PNH Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Treatment of PNH Revenue by Region
  3. 3.2.1 Global Treatment of PNH Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Treatment of PNH Revenue by Region (2021-2026)
  5. 3.2.3 Global Treatment of PNH Revenue by Region (2027-2032)
  6. 3.2.4 Global Treatment of PNH Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Treatment of PNH Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Treatment of PNH Sales by Region
  9. 3.4.1 Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Treatment of PNH Sales by Region (2021-2026)
  11. 3.4.3 Global Treatment of PNH Sales by Region (2027-2032)
  12. 3.4.4 Global Treatment of PNH Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Treatment of PNH Revenue by Manufacturers
  2. 4.1.1 Global Treatment of PNH Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Treatment of PNH Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Treatment of PNH Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Treatment of PNH Sales by Manufacturers
  6. 4.2.1 Global Treatment of PNH Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Treatment of PNH Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Treatment of PNH Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Treatment of PNH Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Treatment of PNH Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Treatment of PNH Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Treatment of PNH Manufacturers, Product Type & Application
  13. 4.7 Global Treatment of PNH Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Treatment of PNH Market CR5 and HHI
  16. 4.8.2 2025 Treatment of PNH Tier 1, Tier 2, and Tier 3
5 Treatment of PNH Market by Type
  1. 5.1 Global Treatment of PNH Revenue by Type
  2. 5.1.1 Global Treatment of PNH Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Treatment of PNH Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Treatment of PNH Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Treatment of PNH Sales by Type
  6. 5.2.1 Global Treatment of PNH Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Treatment of PNH Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Treatment of PNH Sales Market Share by Type (2021-2032)
  9. 5.3 Global Treatment of PNH Price by Type
6 Treatment of PNH Market by Application
  1. 6.1 Global Treatment of PNH Revenue by Application
  2. 6.1.1 Global Treatment of PNH Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Treatment of PNH Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Treatment of PNH Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Treatment of PNH Sales by Application
  6. 6.2.1 Global Treatment of PNH Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Treatment of PNH Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Treatment of PNH Sales Market Share by Application (2021-2032)
  9. 6.3 Global Treatment of PNH Price by Application
7 Company Profiles
  1. 7.1 Alexion Pharmaceuticals
  2. 7.1.1 Alexion Pharmaceuticals Company Information
  3. 7.1.2 Alexion Pharmaceuticals Business Overview
  4. 7.1.3 Alexion Pharmaceuticals Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alexion Pharmaceuticals Treatment of PNH Product Portfolio
  6. 7.1.5 Alexion Pharmaceuticals Recent Developments
  7. 7.2 Apellis Pharmaceuticals
  8. 7.2.1 Apellis Pharmaceuticals Company Information
  9. 7.2.2 Apellis Pharmaceuticals Business Overview
  10. 7.2.3 Apellis Pharmaceuticals Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Apellis Pharmaceuticals Treatment of PNH Product Portfolio
  12. 7.2.5 Apellis Pharmaceuticals Recent Developments
  13. 7.3 Samsung Bioepis
  14. 7.3.1 Samsung Bioepis Company Information
  15. 7.3.2 Samsung Bioepis Business Overview
  16. 7.3.3 Samsung Bioepis Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Samsung Bioepis Treatment of PNH Product Portfolio
  18. 7.3.5 Samsung Bioepis Recent Developments
  19. 7.4 Amgen
  20. 7.4.1 Amgen Company Information
  21. 7.4.2 Amgen Business Overview
  22. 7.4.3 Amgen Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Amgen Treatment of PNH Product Portfolio
  24. 7.4.5 Amgen Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Roche Treatment of PNH Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Treatment of PNH Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Treatment of PNH Product Portfolio
  36. 7.6.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Treatment of PNH Market Size by Type
  2. 8.1.1 North America Treatment of PNH Revenue by Type (2021-2032)
  3. 8.1.2 North America Treatment of PNH Sales by Type (2021-2032)
  4. 8.1.3 North America Treatment of PNH Price by Type (2021-2032)
  5. 8.2 North America Treatment of PNH Market Size by Application
  6. 8.2.1 North America Treatment of PNH Revenue by Application (2021-2032)
  7. 8.2.2 North America Treatment of PNH Sales by Application (2021-2032)
  8. 8.2.3 North America Treatment of PNH Price by Application (2021-2032)
  9. 8.3 North America Treatment of PNH Market Size by Country
  10. 8.3.1 North America Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Treatment of PNH Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Treatment of PNH Market Size by Type
  2. 9.1.1 Europe Treatment of PNH Revenue by Type (2021-2032)
  3. 9.1.2 Europe Treatment of PNH Sales by Type (2021-2032)
  4. 9.1.3 Europe Treatment of PNH Price by Type (2021-2032)
  5. 9.2 Europe Treatment of PNH Market Size by Application
  6. 9.2.1 Europe Treatment of PNH Revenue by Application (2021-2032)
  7. 9.2.2 Europe Treatment of PNH Sales by Application (2021-2032)
  8. 9.2.3 Europe Treatment of PNH Price by Application (2021-2032)
  9. 9.3 Europe Treatment of PNH Market Size by Country
  10. 9.3.1 Europe Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Treatment of PNH Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Treatment of PNH Market Size by Type
  2. 10.1.1 China Treatment of PNH Revenue by Type (2021-2032)
  3. 10.1.2 China Treatment of PNH Sales by Type (2021-2032)
  4. 10.1.3 China Treatment of PNH Price by Type (2021-2032)
  5. 10.2 China Treatment of PNH Market Size by Application
  6. 10.2.1 China Treatment of PNH Revenue by Application (2021-2032)
  7. 10.2.2 China Treatment of PNH Sales by Application (2021-2032)
  8. 10.2.3 China Treatment of PNH Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Treatment of PNH Market Size by Type
  2. 11.1.1 Asia Treatment of PNH Revenue by Type (2021-2032)
  3. 11.1.2 Asia Treatment of PNH Sales by Type (2021-2032)
  4. 11.1.3 Asia Treatment of PNH Price by Type (2021-2032)
  5. 11.2 Asia Treatment of PNH Market Size by Application
  6. 11.2.1 Asia Treatment of PNH Revenue by Application (2021-2032)
  7. 11.2.2 Asia Treatment of PNH Sales by Application (2021-2032)
  8. 11.2.3 Asia Treatment of PNH Price by Application (2021-2032)
  9. 11.3 Asia Treatment of PNH Market Size by Country
  10. 11.3.1 Asia Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Treatment of PNH Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Treatment of PNH Market Size by Type
  2. 12.1.1 SAMEA Treatment of PNH Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Treatment of PNH Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Treatment of PNH Price by Type (2021-2032)
  5. 12.2 SAMEA Treatment of PNH Market Size by Application
  6. 12.2.1 SAMEA Treatment of PNH Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Treatment of PNH Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Treatment of PNH Price by Application (2021-2032)
  9. 12.3 SAMEA Treatment of PNH Market Size by Country
  10. 12.3.1 SAMEA Treatment of PNH Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Treatment of PNH Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Treatment of PNH Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Treatment of PNH Value Chain Analysis
  2. 13.1.1 Treatment of PNH Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Treatment of PNH Production Mode & Process
  6. 13.2 Treatment of PNH Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Treatment of PNH Distributors
  9. 13.2.3 Treatment of PNH Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research